Cargando…

The Combination of β-Asarone and Icariin Inhibits Amyloid-β and Reverses Cognitive Deficits by Promoting Mitophagy in Models of Alzheimer's Disease

β-Asarone is the main constituent of Acorus tatarinowii Schott and exhibits important effects in diseases such as neurodegenerative and neurovascular diseases. Icariin (ICA) is a major active ingredient of Epimedium that has attracted increasing attention because of its unique pharmacological effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Nanbu, Wang, Haoyu, Pan, Qi, Kang, Jian, Liang, Ziwen, Zhang, Ronghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651403/
https://www.ncbi.nlm.nih.gov/pubmed/34887998
http://dx.doi.org/10.1155/2021/7158444
_version_ 1784611389359259648
author Wang, Nanbu
Wang, Haoyu
Pan, Qi
Kang, Jian
Liang, Ziwen
Zhang, Ronghua
author_facet Wang, Nanbu
Wang, Haoyu
Pan, Qi
Kang, Jian
Liang, Ziwen
Zhang, Ronghua
author_sort Wang, Nanbu
collection PubMed
description β-Asarone is the main constituent of Acorus tatarinowii Schott and exhibits important effects in diseases such as neurodegenerative and neurovascular diseases. Icariin (ICA) is a major active ingredient of Epimedium that has attracted increasing attention because of its unique pharmacological effects in degenerative disease. In this paper, we primarily explored the effects of the combination of β-asarone and ICA in clearing noxious proteins and reversing cognitive deficits. The accumulation of damaged mitochondria and mitophagy are hallmarks of aging and age-related neurodegeneration, including Alzheimer's disease (AD). Here, we provide evidence that autophagy/mitophagy is impaired in the hippocampus of APP/PS1 mice and in Aβ1-42-induced PC12 cell models. Enhanced mitophagic activity has been reported to promote Aβ and tau clearance in in vitro and in vivo models. Meanwhile, there is growing evidence that treatment of AD should be preceded by intervention before the formation of pathological products. The efficacy of the combination therapy was better than that of the individual therapies applied separately. Then, we found that the combination therapy also inhibited cell and mitochondrial damage by inducing autophagy/mitophagy. These findings suggest that impaired removal of defective mitochondria is a pivotal event in AD pathogenesis, and that combination treatment with mitophagy inducers represents a potential strategy for therapeutic intervention.
format Online
Article
Text
id pubmed-8651403
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-86514032021-12-08 The Combination of β-Asarone and Icariin Inhibits Amyloid-β and Reverses Cognitive Deficits by Promoting Mitophagy in Models of Alzheimer's Disease Wang, Nanbu Wang, Haoyu Pan, Qi Kang, Jian Liang, Ziwen Zhang, Ronghua Oxid Med Cell Longev Research Article β-Asarone is the main constituent of Acorus tatarinowii Schott and exhibits important effects in diseases such as neurodegenerative and neurovascular diseases. Icariin (ICA) is a major active ingredient of Epimedium that has attracted increasing attention because of its unique pharmacological effects in degenerative disease. In this paper, we primarily explored the effects of the combination of β-asarone and ICA in clearing noxious proteins and reversing cognitive deficits. The accumulation of damaged mitochondria and mitophagy are hallmarks of aging and age-related neurodegeneration, including Alzheimer's disease (AD). Here, we provide evidence that autophagy/mitophagy is impaired in the hippocampus of APP/PS1 mice and in Aβ1-42-induced PC12 cell models. Enhanced mitophagic activity has been reported to promote Aβ and tau clearance in in vitro and in vivo models. Meanwhile, there is growing evidence that treatment of AD should be preceded by intervention before the formation of pathological products. The efficacy of the combination therapy was better than that of the individual therapies applied separately. Then, we found that the combination therapy also inhibited cell and mitochondrial damage by inducing autophagy/mitophagy. These findings suggest that impaired removal of defective mitochondria is a pivotal event in AD pathogenesis, and that combination treatment with mitophagy inducers represents a potential strategy for therapeutic intervention. Hindawi 2021-11-30 /pmc/articles/PMC8651403/ /pubmed/34887998 http://dx.doi.org/10.1155/2021/7158444 Text en Copyright © 2021 Nanbu Wang et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Wang, Nanbu
Wang, Haoyu
Pan, Qi
Kang, Jian
Liang, Ziwen
Zhang, Ronghua
The Combination of β-Asarone and Icariin Inhibits Amyloid-β and Reverses Cognitive Deficits by Promoting Mitophagy in Models of Alzheimer's Disease
title The Combination of β-Asarone and Icariin Inhibits Amyloid-β and Reverses Cognitive Deficits by Promoting Mitophagy in Models of Alzheimer's Disease
title_full The Combination of β-Asarone and Icariin Inhibits Amyloid-β and Reverses Cognitive Deficits by Promoting Mitophagy in Models of Alzheimer's Disease
title_fullStr The Combination of β-Asarone and Icariin Inhibits Amyloid-β and Reverses Cognitive Deficits by Promoting Mitophagy in Models of Alzheimer's Disease
title_full_unstemmed The Combination of β-Asarone and Icariin Inhibits Amyloid-β and Reverses Cognitive Deficits by Promoting Mitophagy in Models of Alzheimer's Disease
title_short The Combination of β-Asarone and Icariin Inhibits Amyloid-β and Reverses Cognitive Deficits by Promoting Mitophagy in Models of Alzheimer's Disease
title_sort combination of β-asarone and icariin inhibits amyloid-β and reverses cognitive deficits by promoting mitophagy in models of alzheimer's disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651403/
https://www.ncbi.nlm.nih.gov/pubmed/34887998
http://dx.doi.org/10.1155/2021/7158444
work_keys_str_mv AT wangnanbu thecombinationofbasaroneandicariininhibitsamyloidbandreversescognitivedeficitsbypromotingmitophagyinmodelsofalzheimersdisease
AT wanghaoyu thecombinationofbasaroneandicariininhibitsamyloidbandreversescognitivedeficitsbypromotingmitophagyinmodelsofalzheimersdisease
AT panqi thecombinationofbasaroneandicariininhibitsamyloidbandreversescognitivedeficitsbypromotingmitophagyinmodelsofalzheimersdisease
AT kangjian thecombinationofbasaroneandicariininhibitsamyloidbandreversescognitivedeficitsbypromotingmitophagyinmodelsofalzheimersdisease
AT liangziwen thecombinationofbasaroneandicariininhibitsamyloidbandreversescognitivedeficitsbypromotingmitophagyinmodelsofalzheimersdisease
AT zhangronghua thecombinationofbasaroneandicariininhibitsamyloidbandreversescognitivedeficitsbypromotingmitophagyinmodelsofalzheimersdisease
AT wangnanbu combinationofbasaroneandicariininhibitsamyloidbandreversescognitivedeficitsbypromotingmitophagyinmodelsofalzheimersdisease
AT wanghaoyu combinationofbasaroneandicariininhibitsamyloidbandreversescognitivedeficitsbypromotingmitophagyinmodelsofalzheimersdisease
AT panqi combinationofbasaroneandicariininhibitsamyloidbandreversescognitivedeficitsbypromotingmitophagyinmodelsofalzheimersdisease
AT kangjian combinationofbasaroneandicariininhibitsamyloidbandreversescognitivedeficitsbypromotingmitophagyinmodelsofalzheimersdisease
AT liangziwen combinationofbasaroneandicariininhibitsamyloidbandreversescognitivedeficitsbypromotingmitophagyinmodelsofalzheimersdisease
AT zhangronghua combinationofbasaroneandicariininhibitsamyloidbandreversescognitivedeficitsbypromotingmitophagyinmodelsofalzheimersdisease